Sustanon 250, solution injectable
IJB-SP01-2025
Phase 2 small_molecule active
Quick answer
Sustanon 250, solution injectable for Androgen deficiency, palliative care is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Androgen deficiency, palliative care
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active